Lupus anticoagulant associated with transient severe factor X deficiency: A report of two patients presenting with major bleeding complications

British Journal of Haematology

Volumn 121, Issue 4, 2003, Pages 639-642

  Ashrani, Aneel A ^a   Aysola, Agnes ^a   Al Khatib, Hani ^b   Nichols, William L ^c   Key, Nigel S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b U of MN St Cloud Hospital FMR   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Acquired factor X deficiency; Bleeding disorder bleeding diathesis; Lupus anticoagulant; Respiratory infection

Indexed keywords

LUPUS ANTICOAGULANT;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLEEDING DISORDER; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CASE REPORT; COMPLEX FORMATION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPOPROTHROMBINEMIA; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ANTIBODIES, ANTIPHOSPHOLIPID; FACTOR X DEFICIENCY; HEMORRHAGIC DISORDERS; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS;

EID: 0038730598     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04325.x     Document Type: Article

References (12)

1. Arnout, J. (2001) Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thrombosis Haemostasis, 86, 83-91.
2. Boggio, L. & Green, D. (2001) Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency. British Journal of Haematology, 112, 1074-1075.
3. Choufani, E.B., Sanchorawala, V., Ernst, T., Quillen, K., Skinner, M., Wright, D.G. & Seldin, D.C. (2001) Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood, 97, 1885-1887.
4. Currie, M.S., Stein, A.M., Rustagi, P.K., Behrens, A.N. & Logue, G.L. (1984) Transient acquired factor X deficiency associated with pneumonia. New York State Journal of Medicine, 84, 572-573.
5. Edson, J.R., Vogt, J.M. & Hasegawa, D.K. (1984) Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood, 64, 807-816.
6. Galli, M. & Barbui, T. (1999) Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood, 93, 2149-2157.
7. Jones, D.W., Gallimore, M.J., MacKie, I.J., Harris, S.L. & Winter, M. (2000) Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. British Journal of Haematology, 110, 721-726.
8. Lankiewicz, M.W. & Bell, W.R. (1992) A unique circulating inhibitor with specificity for coagulation factor X. American Journal of Medicine, 93, 343-346.
9. Lee, M.T., Nardi, M.A., Hadzi-Nesic, J. & Karpatkin, M. (1996) Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. American Journal of Hematology, 51, 307-314.
10. Mulhare, P.E., Tracy, P.B., Golden, E.A., Branda, R.F. & Bovill, E.G. (1991) A case of acquired factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against factor X. American Journal of Clinical Pathology, 96, 196-200.
11. Peuscher, F.W., van Aken, W.G., van Mourik, J.A., Swaak, A.J., Sie, L.H. & Statius van Eps, L.W. (1979) Acquired, transient factor X (Stuart factor) deficiency in patient with mycoplasma pneumonial infection. Scandinavian Journal of Haematology, 23, 257-264.
12. Peyvandi, F. & Mannucci, P.M. (1999) Rare coagulation disorders. Thrombosis and Haemostasis, 82, 1207-1214.